Immunocept Medical Products

Denver, United States Founded: 1999 • Age: 27 yrs Acquired By CytoPherx
Blood filtration therapy for severe sepsis is developed.
Request Access

About Immunocept Medical Products

Immunocept Medical Products is a company based in Denver (United States) founded in 1999 was acquired by CytoPherx in June 2018.. Immunocept Medical Products has raised $530 thousand across 1 funding round from investors including CytoPherx. Immunocept Medical Products operates in a competitive market with competitors including Haemonetics, Vetex Medical, MediSieve, Immutrix Therapeutics and Hemostasis, among others.

  • Headquarter Denver, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Immunocept Medical Products, Llc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $530 K (USD)

    in 1 rounds

  • Latest Funding Round
    $530 K (USD), Unspecified

    Aug 02, 2017

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    CytoPherx

    (Jun 30, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Immunocept Medical Products

Immunocept Medical Products has successfully raised a total of $530K through 1 strategic funding round. The most recent funding activity was a Unspecified round of $530 thousand completed in August 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Unspecified — $530,000
  • First Round

    (02 Aug 2017)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2017 Amount Unspecified - Immunocept Medical Products Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Immunocept Medical Products

Immunocept Medical Products has secured backing from 1 investor. Prominent investors backing the company include CytoPherx. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Cytopheresis systems for inflammatory conditions
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Immunocept Medical Products

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Immunocept Medical Products

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Immunocept Medical Products Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Immunocept Medical Products

Immunocept Medical Products operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Haemonetics, Vetex Medical, MediSieve, Immutrix Therapeutics and Hemostasis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Hematology products and solutions are provided for medical applications.
domain founded_year HQ Location
Catheters for venous clot management and removal are developed.
domain founded_year HQ Location
Magnetic therapy is developed to treat blood-borne diseases.
domain founded_year HQ Location
Blood cleansing treatment device
domain founded_year HQ Location
Develops and manufactures hemostatic products for surgical bleeding control and patient care.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Immunocept Medical Products

Frequently Asked Questions about Immunocept Medical Products

When was Immunocept Medical Products founded?

Immunocept Medical Products was founded in 1999 and raised its 1st funding round 18 years after it was founded.

Where is Immunocept Medical Products located?

Immunocept Medical Products is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.

Is Immunocept Medical Products a funded company?

Immunocept Medical Products is a funded company, having raised a total of $530K across 1 funding round to date. The company's 1st funding round was a Unspecified of $530K, raised on Aug 02, 2017.

What does Immunocept Medical Products do?

Immunocept Medical Products is a clinical stage medical device company with a platform blood filtration therapy for severe sepsis and other diseases of destructive inflammation.The company targets the 1B plus severe sepsis market. The company claims to have 11 US patents, finished clinical devices and IDE approval for our feasibility study. The SeptiFlux is a hollow fiber, very large-pore membrane blood filter that differs from other hemofilters because it is designed to remove a significant fraction of every type and size of inflammatory signal circulating in the blood.

Who are the top competitors of Immunocept Medical Products?

Immunocept Medical Products's top competitors include Haemonetics, Vetex Medical and MediSieve.

Who are Immunocept Medical Products's investors?

Immunocept Medical Products has 1 investor. Key investors include CytoPherx.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available